Effective Strategies for Management of Hypertension After Vascular Endothelial Growth Factor Signaling Inhibition Therapy: Results From a Phase II Randomized, Factorial, Double-Blind Study of Cediranib in Patients With Advanced Solid Tumors

M.H.G. Langenberg, C.M.L. van Herpen, J. De Bono, J.H.M. Schellens, C. Unger, K. Hoekman, H.E. Blum, W. Fiedler, J. Drevs, F. Le Maulf, A. Fielding, J. Robertson, E.E. Voest

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)6152-6159
JournalJournal of Clinical Oncology
Issue number36
Publication statusPublished - 2009

Cite this